Pipeline
Learn about our Pipeline
Committed to responsible impact
Caring responsibly for patients and society
Our approach to corporate responsibility is rooted in our commitment to the movement disorder and neurology communities we serve. We are empowered to make decisions based on the real needs of patients, their families and the healthcare professionals who care for them — guided by compassion, accountability and scientific integrity.
Across Merz Therapeutics, we strive to ensure that every decision we make reflects our long-term commitment to care, compliance and sustainable progress.
Our sustainability focus areas
We accelerate sustainable impact by expanding our reach and operations to drive long-term, responsible growth — delivering better outcomes for more patients, while reducing our environmental footprint and creating lasting social value.
Working together for the good of patients is at the heart of our strategy. It reflects our purpose and drives everything we do — from innovation and sustainability to people development and ethical leadership. Every step we take is aimed at improving lives and delivering better health outcomes.
We continuously evaluate and raise employee awareness of our environmental footprint, recognizing that patient wellbeing is closely tied to a healthy planet. That’s why we’re committed to minimizing our environmental impact, focusing on what matters most: reducing climate-related emissions, cutting waste and improving recycling and packaging practices.
Our goal is to build a sustainable work-life balance and a vibrant, inclusive workplace where people feel free to be themselves so they can thrive and do their best work.
We take a long-term, impact-driven approach to advancing care — guided by scientific rigor, ethical principles and accountability at every level of the organization. Through sustainable clinical research, responsible innovation and robust governance frameworks, we aim to uphold integrity with stakeholders, support patients beyond treatment and deliver lasting value for society.
Ethics & compliance
Comprehensive Compliance Program (CCP)
Merz Therapeutics U.S., a business of Merz Pharmaceuticals, LLC (“Merz”) is committed to setting high corporate ethical standards while providing quality products and services that comply with applicable federal, state and local laws and regulations.
Merz has developed and adopted a CCP in accordance with the Compliance Program Guidance for Pharmaceutical Manufacturers published by the Office of Inspector General of the U.S. Department of Health and Human Services (OIG Guidance). Merz also incorporates policies that comply with the Pharmaceutical Research and Manufacturers of America (PhRMA) Code on Interactions with Healthcare Professionals. Merz intends for this program to meet the requirements of all applicable federal and state laws.
Merz is committed to transparency in its relationships with healthcare providers. It collects, tracks, and reports transfers of value to healthcare providers and organizations in compliance with all applicable disclosure and transparency laws.
As part of Merz’s commitment to operating ethically and in compliance with applicable laws and regulations, Merz declares that it has established a CCP, which is also designed to meet the requirements of the California Health and Safety Code § 119400-119402. For the full California Declaration click here.
For a copy of Merz’s CCP or to contact Merz’s Compliance Department, email us at NATxCompliance@merz.com.
Vermont law 33 V.S.A. § 2005a requires pharmaceutical marketers to disclose to individuals authorized to prescribe prescription drugs in Vermont the Average Wholesale Prices (AWP) of the prescription drugs in pill form (e.g., tablets, capsules) that they market as well as the prices of other drugs in the same therapeutic class.
Long Form: AMPYRA® (dalfampridine)
Short Form: AMPYRA® (dalfampridine)
Grants & Giving
Merz is committed to providing meaningful support for healthcare providers (HCPs) and patients in the movement disorder community.
Through our Grants and Giving program, we provide support for commercial programs/exhibits, educational programs, resident training and investigator-initiated trials (IITs).
Educational support
Merz accepts unsolicited requests for the funding of educational activities that advance the knowledge, skill and proficiency of medical professionals in the movement disorder space. With this goal in mind, we provide grants for both CME accredited and independent medical educational programs.
Resident training
Residents and fellows may submit an unsolicited grant request for Merz products to support educational and training programs.
Investigator-initiated trials (IITs)
Merz accepts unsolicited applications for investigator-initiated trials (IITs). Pending final approval by our Grants and Giving Committee, we may choose to provide support for such trials by providing grant product (drug/device), financial and other study-related support.
Publication support
Merz encourages HCPs to communicate clinical data, case studies, review topics and other substantive new information that furthers the scientific and clinical understanding of our products. We accept unsolicited requests for publication support, provided by an independent third party of the authors’ choosing. Following Good Publication Practice guidelines, we require that authors disclose any support upon publication.
Commercial partnerships
Our commercial sponsorship grants focus on U.S. industry meetings in neurology and movement disorders.*
*Merz has formal separation between the Medical Affairs and Commercial grant review processes. In turn, we request that applicants submit separate applications for commercial support/exhibit requests and educational support.
Charitable giving
Merz Therapeutics U.S. provides charitable support to local and national organizations through our Merz Cares charitable giving initiative.
Our primary focus areas include, movement disorders, U.S. military members and veterans, healthcare access, women’s empowerment and issues related to improving diversity, equality and inclusion in healthcare.
501c3, not-for-profit organizations can learn more and request funding here.
For additional information or questions about Merz Therapeutics U.S. Grants & Giving, please contact us at Grants.US@merz.com.
Supplier diversity
Merz seeks business opportunities with a variety of diverse suppliers and invites you to let us know about what products and services you provide. Our vendors demonstrate that they can provide high-quality goods and services that are competitively priced, reliable and consistent with our mission to deliver better outcomes for more patients.
If you are interested in doing business with Merz please complete and submit the following Supplier Registration Form to Vendors.Tx@merz.com, and you will be added to our Supplier Database. Inclusion in the Supplier Database does not guarantee any engagement with Merz. Merz does not discriminate based on any legally protected class.
